Unresolved issues in biologic therapy for rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Unresolved issues in biologic therapy for rheumatoid arthritis.

Unresolved issues in biologic therapy for rheumatoid arthritis.

http://www.wikidata.org/entity/Q37851001

about

Structural integrity versus radiographic progression in rheumatoid arthritis Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review.Etanercept-Synthesising Mesenchymal Stem Cells Efficiently Ameliorate Collagen-Induced Arthritis.Immunotherapeutic implication of IL-6 blockade.Novel mechanisms of action of the biologicals in rheumatic diseases.Rationally designed less toxic SPD-304 analogs and preliminary evaluation of their TNF inhibitory effects.Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists.First face-off in RA biologic therapy declared a draw.A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE

P2860

Q26777897-33239F03-7222-4ECC-A862-A4FB52062AAF Q30240229-0CA33729-007D-481C-90E5-B0B56ED11BCD Q37584714-73A74384-19E2-4001-A5B1-BA1E02E32F01 Q37965754-6E721B93-3ECB-4B26-AC22-9FAD1DF59167 Q38076350-01CBD4B8-FC53-4584-901A-D1BDF1437C65 Q38962569-0FD8D620-C3E8-402D-ABEA-FE5EE0E7310B Q39191675-C01C038C-2667-4A23-B89C-B13D913D1159 Q44969445-C7CA2533-22C4-47CC-87E3-0208018D1257 Q58787844-BBD8D3E4-A4C0-4226-AB97-C10F4CC9A8EA

P2860

Unresolved issues in biologic therapy for rheumatoid arthritis.

http://www.wikidata.org/entity/Q37851001

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Unresolved issues in biologic therapy for rheumatoid arthritis.

@en

Unresolved issues in biologic therapy for rheumatoid arthritis.

@nl

type

label

Unresolved issues in biologic therapy for rheumatoid arthritis.

@en

Unresolved issues in biologic therapy for rheumatoid arthritis.

@nl

prefLabel

Unresolved issues in biologic therapy for rheumatoid arthritis.

@en

Unresolved issues in biologic therapy for rheumatoid arthritis.

@nl

P1433

Q37851001-92E9F837-EADD-4CF0-9C48-B8D71825BF88

P1476

Q37851001-F4DD188E-B3CF-4034-A6E9-66B325580928

P2860

Q37851001-00D8B3EC-D099-4EFE-8827-D59207C5F18E

Q37851001-00F3842B-1154-4482-9009-B37C6B6D4A05

Q37851001-04973A8A-BC16-46D2-A899-063B4346A598

Q37851001-09A6243E-BA03-42D2-9678-E041AD2D44DF

Q37851001-0A0D9543-D6BA-45F0-9DB3-3D9FEBBE36D9

Q37851001-0A822165-0FA4-4E12-8899-D103E388FED6

Q37851001-0DF089C9-2E00-4F32-AAFB-BE188073DA01

Q37851001-1106A1CB-5053-4852-B0BE-7AB1CB3D83C8

Q37851001-111E2664-2A0B-45EF-B3DA-66AE45AFF976

Q37851001-12A5D795-1831-4A4E-BF9C-5143AFB148CB

P2888

Q37851001-99344264-EA51-4E38-ACC5-22DB78612975

P304

Q37851001-18FDAA12-DD96-44A0-8B96-EAD40E359A66

P31

Q37851001-9666E442-1B81-4EB9-99C1-939A4FB15875

P356

Q37851001-DAAC64EB-1C69-4DFA-85B1-A622D14EF420

P407

Q37851001-6AAE1AF4-E01C-4A39-906E-E4E333E45390

P433

Q37851001-FD7B624C-6BEE-47CD-BDD5-4C13778D566B

P478

Q37851001-D2EA9615-D003-452D-A423-25FA273FB0CD

P50

Q37851001-3B977A00-9249-4E70-848A-78275A160FFA

P577

Q37851001-B14FCA01-11D1-4811-9889-E45563948AB1

P698

Q37851001-3AEE513C-1EBA-468B-AFA4-ACC6833E4669

P356

NRRHEUM.2011.22

P1433

Nature Reviews Rheumatology

P1476

Unresolved issues in biologic therapy for rheumatoid arthritis.

@en

P2860

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.

Comparative effectiveness and health care spending--implications for reform.

The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab'

Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness.

P2888

nrrheum.2011.22

P304

205-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2011.22

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Ronald van Vollenhoven

P577

2011-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21386796

http://www.w3.org/2001/XMLSchema#string